![Diane J. Kalina](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Diane J. Kalina
President chez BioCatalyst Yorkton, Inc.
Postes actifs de Diane J. Kalina
Sociétés | Poste | Début | Fin |
---|---|---|---|
BioCatalyst Yorkton, Inc. | Directeur/Membre du Conseil | 17/01/2011 | - |
President | 01/01/2005 | - |
Historique de carrière de Diane J. Kalina
Anciens postes connus de Diane J. Kalina
Sociétés | Poste | Début | Fin |
---|---|---|---|
Arius Research, Inc.
![]() Arius Research, Inc. BiotechnologyHealth Technology Arius Research, Inc. develops anti-cancer antibodies. The company is headquartered in Toronto, Canada. | Directeur/Membre du Conseil | 01/04/2003 | 06/12/2007 |
YM BioSciences, Inc.
![]() YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Directeur/Membre du Conseil | - | - |
President | - | - | |
GSK Products, Inc.
![]() GSK Products, Inc. Wholesale DistributorsDistribution Services Part of Princeton American Corp., GSK Products, Inc. is a beauty and barber supply concern. The company is based in Phoenix, AZ. | Sales & Marketing | - | - |
PDC Biotech GmbH
![]() PDC Biotech GmbH BiotechnologyHealth Technology PDC Biotech GmbH operates as a biopharmaceutical company developing innovative therapeutics for the treatment of preterm labor and primary dysmenorrheal in women. The firm’s pipeline products include prostaglandin F2a (FP) receptor antagonists, PDC31 a synthetic octapeptide, which is designed to act as an allosteric modulator of the receptor for prostaglandin FP receptor. The company was founded by Patricia Griffin and Diane J. Kalina in May 2008 and is headquartered in Vienna, Austria. | Directeur Général | 01/05/2008 | - |
Fondateur | 01/05/2008 | - | |
E3 LITHIUM LIMITED | Directeur Financier/CFO | - | - |
Statistiques
Internationale
Canada | 4 |
Royaume-Uni | 2 |
Etats-Unis | 2 |
Opérationnelle
Director/Board Member | 3 |
President | 2 |
Director of Finance/CFO | 1 |
Sectorielle
Health Technology | 4 |
Process Industries | 2 |
Distribution Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
E3 LITHIUM LIMITED | Process Industries |
Entreprise privées | 5 |
---|---|
YM BioSciences, Inc.
![]() YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Health Technology |
Arius Research, Inc.
![]() Arius Research, Inc. BiotechnologyHealth Technology Arius Research, Inc. develops anti-cancer antibodies. The company is headquartered in Toronto, Canada. | Health Technology |
GSK Products, Inc.
![]() GSK Products, Inc. Wholesale DistributorsDistribution Services Part of Princeton American Corp., GSK Products, Inc. is a beauty and barber supply concern. The company is based in Phoenix, AZ. | Distribution Services |
BioCatalyst Yorkton, Inc. | |
PDC Biotech GmbH
![]() PDC Biotech GmbH BiotechnologyHealth Technology PDC Biotech GmbH operates as a biopharmaceutical company developing innovative therapeutics for the treatment of preterm labor and primary dysmenorrheal in women. The firm’s pipeline products include prostaglandin F2a (FP) receptor antagonists, PDC31 a synthetic octapeptide, which is designed to act as an allosteric modulator of the receptor for prostaglandin FP receptor. The company was founded by Patricia Griffin and Diane J. Kalina in May 2008 and is headquartered in Vienna, Austria. | Health Technology |
- Bourse
- Insiders
- Diane J. Kalina
- Expérience